This execution block purports to reflect a new personal consent from Samuel Brooks, who died in 2023. It should not be presented as validly executed without resolving this discrepancy and confirming the proper successor authority.
Marissa read it twice.
Then examined the responses.
The supervising partner had forwarded the concern to Daniel Mercer.
Daniel acknowledged receipt.
A later message instructed the transaction team to continue preparing the board packet while the concern was supposedly being resolved.
Then another communication, sent by Graham Whitlock to Daniel, stated that the transaction could not tolerate another delay and that the executive team expected the consent issue to be settled before the next morning.
Marissa studied the sequence.
It didn't prove every element of intent by itself.
But it contradicted Graham's claim that no one had been aware of the problem.
The issue had been raised.
The people responsible for the transaction received the warning.
And the final certificate was still presented to the board.
Marissa called an emergency meeting of the special committee.
Arthur Bellamy attended.
So did the independent directors and several advisers.
For nearly three hours, they reviewed the records.
Then Arthur asked the question he'd been avoiding.
“Did Graham know the certificate represented Samuel as signing after his death?”
Marissa answered carefully.
“The communications establish that the problem was brought to the legal team's attention and that senior transaction personnel were pressing for execution. Determining exactly what Graham understood at each stage requires further investigation.”
Arthur looked toward the window.
For a moment, he seemed exhausted.
Then asked.
“Could the board have signed a binding agreement based on that certificate?”
Marissa nodded.
“The consequences would depend on the agreement and applicable law, but executing a transaction while relying on an apparently invalid consent could have created significant legal and financial problems.”
One director leaned forward.
“Even if the founder trust ultimately had no effective veto?”
“Yes.”
Marissa looked toward him.
“False execution representations are serious regardless of whether some other legal path to approval might have existed.”
The room became silent.
Then Arthur looked down at the document.
He remembered Samuel's face.
His laughter.
The arguments they had over licensing fees.
And the promise he'd made when Northstar first accepted major institutional investment.
He took a breath.
“Then the company needs to know whether it has been told the truth.”
Marissa nodded.
“That is precisely what we're investigating.”
Naomi met a Northstar hospital customer the following week.
The meeting wasn't arranged as a publicity event.